CNTB - Connect Biopharma - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-906.6M

Cash

951M

Avg Qtr Burn

-138.2M

Short % of Float

0.05%

Insider Ownership

39.86%

Institutional Own.

39.87%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Rademikibart (CBP-201) (Th2 cell modulator) Details Atopic dermatitis Big Mover™ Suspected Mover™ Susp. Mover™	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CBP-201 (Th2 cell modulator) Details Asthma Big Mover™ Suspected Mover™ Susp. Mover™	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Icanbelimod (CBP-307) (Small molecule targeting S1P1) (Th1 cell modulator) Details Ulcerative colitis	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CBP-174 (Peripherally restricted H3 receptor antagonist) Details Chronic pruritus	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Icanbelimod (CBP-307) (Small molecule targeting S1P1) (Th1 cell modulator) Details Crohns disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CBP-201 (Th2 cell modulator) Details Chronic rhinosinusitis, Chronic rhinosinusitis with nasal polyps	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.